SPL 3.85% 12.5¢ starpharma holdings limited

Ann: US patent issued for DEP cabazitaxel nanoparticle, page-2

  1. 15,093 Posts.
    lightbulb Created with Sketch. 5368
    If this is what the secret squirrel stuff some were going on about earlier in the week, it is a bit of a fizzer .... good to see the patent granted but realistically it is not like it wasn't expected ? I mean who else were they going to award the patent to for DEP® cabazitaxel ?

    It's not like Sanofi could dispute it as they don't own the DEP technology and let's face it, Starpharma didn't even nominate the announcement as price sensitive for the reasons I have outlined above

    I guess we will see if Sanofi are interested enough in it to sign a deal whenever the trials finish next year (or the year after knowing SPL) ... we all know how DEP® Remdesivir went - JF is still waiting for Gilead to return her call IMO ?
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
12.5¢
Change
-0.005(3.85%)
Mkt cap ! $51.50M
Open High Low Value Volume
12.5¢ 13.0¢ 12.5¢ $44.65K 352.2K

Buyers (Bids)

No. Vol. Price($)
1 7680 12.5¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 135727 8
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
13.0¢
  Change
-0.005 ( 4.00 %)
Open High Low Volume
13.0¢ 13.0¢ 13.0¢ 52582
Last updated 15.59pm 29/03/2024 ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.